http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_82a51e78a6e59619d2097b41be7b6f6e
Outgoing Links
| Predicate | Object |
|---|---|
| family-name | Brufsky |
| name | Adam Brufsky |
| given-name | Adam |
| organization-name | Department of Medicine, University of Pittsburgh, Pittsburgh, PA, United States From the Magee-Womens Hospital, University of Pittsburgh Cancer Institute, Pittsburgh, PA; Utah Cancer Specialists, Salt Lake City, UT; Highlands Oncology Group, Springdale, AK; North Florida Regional Medical Center, Gainesville; Cancer Research Network, Plantation; Mayo Clinic, Jacksonville, FL; Fallon Clinic Hematology Oncology, Worcester, MA; and Novartis Oncology, East Hanover, NJ Magee-Womens Hospital of UPMC, Pittsburgh, PA University of Pittsburgh Cancer Institute Magee‐Women’s Hospital Pittsburgh Pennsylvania NSABP Foundation and NRG Oncology, Pittsburgh, PA, USA; UPMC Hillman Cancer Center, Magee Women’s Hospital University of Pittsburgh, Pittsburgh, PA, USA Magee-Womens Hospital of University of Pittsburgh Medical Center, 15213, Pittsburgh, Pennsylvania, USA Division of Hematology and Oncology; University of Pittsburgh; Pittsburgh Pennsylvania Hillman Cancer Center, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania, USA Department of Medicine, University of Pittsburgh School of Medicine, UPMC Liver Cancer Center, Pittsburgh, PA 15213, USA 4University of Pittsburgh Cancer Institute and UPMC Cancer Center, Pittsburgh, Pennsylvania. Division of Hematology/Oncology, University of Pittsburgh Medical Center, Pittsburgh, PA 15213, USA. Department of Medicine, Division of Hematology/Oncology, UPMC Hillman Cancer Center University of Pittsburgh Medical Center Pittsburgh Pennsylvania USA Magee-Women’s Hospital and the Hillman Cancer Center, University of Pittsburgh Medical Center, Pittsburgh, PA, USA Division of Hematology and Oncology, University of Pittsburgh Cancer Institute; 300 Halket Street, Room 3524 Pittsburgh PA From the Department of Epidemiology (S.Y.J., F.L., J.L.W., S.M.S.), Graduate School of Public Health, University of Pittsburgh, Pittsburgh, PA; Department of Medicine (F.L., A.B., J.L.W.), University of Pittsburgh School of Medicine, Pittsburgh, PA; University of Pittsburgh Cancer Institute (M.R., A.B., J.L.W.), Pittsburgh, PA; Department of Biostatistics (S.M.S.), Graduate School of Public Health, University of Pittsburgh, Pittsburgh, PA; University of Pittsburgh School of Nursing (M.S., S.M.S.),... From the Division of Medical Oncology, British Columbia Cancer Agency, University of British Columbia, Vancouver, British Columbia, Canada; Division of Hematology and Medical Oncology, Feinberg School of Medicine, Northwestern University, Chicago, IL; Department of Medical Oncology, Institut Bergonié, Bordeaux; Department of Medical Oncology, CRLC Val d’ Aurelle-Paul Lamarque, Montpellier, France; Medical Oncology, Instituto National de Cancer, Rio de Janeiro; Departmento de Radiologia, Faculdade de... Edward H. Romond, Jong-Hyeon Jeong, Priya Rastogi, Sandra M. Swain, Charles E. Geyer Jr, Louis Fehrenbacher, Adam Brufsky, Catherine A. Azar, Patrick J. Flynn, John L. Zapas, Jonathan Polikoff, Howard M. Gross, David D. Biggs, James N. Atkins, Ping Zheng, Greg Yothers, Eleftherios P. Mamounas, and Norman Wolmark, National Surgical Adjuvant Breast and Bowel Project Operations and Biostatistical Center; Jong-Hyeon Jeong, Ping Zheng, and Greg Yothers, Graduate School of Public Health, University of... 15University of Pittsburgh, Magee Women's Hospital, Pittsburgh, Pennsylvania, Division of Hematology/Oncology, University of Pittsburgh, Pittsburgh, PA, USA; 3Department of Medicine, University of Pittsburgh Cancer Institute, Pittsburgh, Pennsylvania. Division of Hematology-Oncology; University of Pittsburgh; Pittsburgh; PA University of Pittsburgh Cancer Institute, Pittsburgh, PA, USA 6University of Pittsburgh Cancer Institute, University of Pittsburgh Cancer Institute, Pittsburgh, Pennsylvania. University of Pittsburgh School of Medicine, Department of Medicine, Division of Hematology/Oncology, UPMC Hillman Cancer Center, Pittsburgh, Pennsylvania 15232, United States From the Cancer Therapeutics Branch, Medical Oncology Clinical Research Unit, and Biostatistics and Data Management Section, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD; and the Magee-Women's Hospital, University of Pittsburgh Cancer Institute, Pittsburgh, PA Department of Medicine, University of Pittsburgh Medical Center, Pittsburgh, PA, USA Dennis C. Sgroi, Massachusetts General Hospital, Charlestown and Boston, MA; and Adam Brufsky, University of Pittsburgh Medical Center, Pittsburgh, PA UPMC Hillman Cancer Center, Magee Women's Hospital, Suite 4628, 300 Halket Street, Pittsburgh, PA 15213, USA From the University of Pittsburgh, Department of Medicine, Magee Womens Hospital/University of Pittsburgh Breast Program; University of Pittsburgh Medical Center Hillman Cancer Center; Departments of Medicine, Biostatistics, Health and Community Systems, Biostatistics, and Epidemiology, University of Pittsburgh, Pittsburgh, PA; and the Department of Medicine, University of Kansas, Kansas City, KS University of Pittsburgh Cancer Institute, Pittsburgh, Pennsylvania, USA (A.M., A.B.) Division of Hematology/Oncology, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA. Department of Medicine, Division of Hematology/Oncology, University of Pittsburgh Cancer Institute, Pittsburgh, PA 15232, USA *Department of Medicine and Division of Hematology/Oncology, University of Pittsburgh School of Medicine, Pittsburgh, PA 15213; Magee-Womens Hospital, Pittsburgh, Pennsylvania 15123, USA. brufskyam@upmc.edu Department of Medicine (S.L.G., A.B., V.G.V.), University of Pittsburgh, Pittsburgh, Pennsylvania 15213; Magee Women’s Hospital/University of Pittsburgh Breast Program (V.G.V., A.B.), University of Pittsburgh, Pittsburgh, Pennsylvania 15213 Cristina Saura, MD, PhD and Mafalda Oliveira, MD, PhD, Vall d’Hebron University Hospital, Vall d’Hebron Institute of Oncology (VHIO), SOLTI Breast Cancer Cooperative Group, Barcelona, Spain; Sung-Bae Kim, MD, PhD, University of Ulsan College of Medicine, Seoul, Republic of Korea; Thomas Yau, MD, MBBS, Li Ka Shing Faculty of Medicine, University of Hong Kong, Hong Kong, China, Toshimi Takano, MD, Toranomon Hospital, Tokyo, Japan; and Adam Brufsky, MD, PhD, Magee-Womens Hospital of UPMC, Pittsburgh, PA Noah Kornblum, Della F. Makower, and Joseph A. Sparano, Albert Einstein College of Medicine, Bronx; Paula Klein, Mount Sinai Beth Israel Comprehensive Cancer Center, New York, NY; Fengmin Zhao and Judith Manola, Dana-Farber Cancer Institute, Boston, MA; Bhuvaneswari Ramaswamy, The Ohio State University Comprehensive Cancer Center, Columbus, OH; Adam Brufsky, University of Pittsburgh, Pittsburgh; Cristina I. Truica, Penn State Cancer Institute, Hershey; Lori J. Goldstein, Fox Chase Cancer Center,... From the Department of Human Genetics, Graduate School of Public Health (D.G.P., E.H-O., R.E.F.), Department of Hematology/Oncology, School of Medicine (A.B.), and Department of Neurosurgery, School of Medicine (A.B.K., H.Y.), University of Pittsburgh (Pa). UPMC Hillman Cancer Center, University of Pittsburgh Medical Center, Pittsburgh, PA, USA Magee‐Women's Hospital University of Pittsburgh School of Medicine Pittsburgh PA USA From the Departments of Pathology (Dr Esposito) and Biostatistics (Dr Lin), University of Pittsburgh, Pittsburgh, Pa; the Department of Pathology, Cedar Sinai Medical Center, University of California, Los Angeles (Dr Mohan); and the Departments of Hematology/Oncology (Dr Brufsky) and Pathology (Drs Kapali and Dabbs), Magee-Womens Hospital, University of Pittsburgh Medical Center, Pittsburgh, Pa Authors' Affiliations: 1Complutense University and Hospital General Universitario Gregorio Maranon, Servicio De Oncologia Medica, Madrid, Spain; 2Andrew Love Cancer Centre, Barwon Health, Geelong, Victoria, Australia; 3Clinique Victor Hugo–Centre Jean Bernard, Cedex 2, France; 4University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania; 5Onkologische Schwerpunktpraxis, Mannheim, Germany; 6Institutul Oncologic Ion Chiricuta, Cluj-Napoca, Romania; 7Cancer Research UK, University of Sussex, Falmer, Brighton, United Kingdom; 8National Cancer Center Hospital, Tokyo, Japan; 9Medical University of Gdansk, Gdańsk, Poland; 10Tom Baker Cancer Centre, Calgary, Alberta, Canada; 11Beatson Oncology Centre, Glasgow, Scotland, United Kingdom; 12Allgemeines Krankenhaus St. Georg, Clinical Division of Oncology, Waehringer Guertel, Vienna, Austria; 13Arizona Cancer Center, University of Arizona, Tucson, Arizona; 14Sylvester Comprehensive Cancer Center at Deerfield, Deerfield Beach, Florida; and Departments of 15Biostati University of Pittsburgh Medical Center Hillman Cancer Center, Pittsburgh, PA, USA University of Pittsburgh Medical Center Magee‐Womens Hospital Pittsburgh Pennsylvania USA; Division of Hematology/Oncology School of Medicine University of Pittsburgh Pittsburgh Pennsylvania USA 2University of Pittsburgh Cancer Institute, Pittsburgh, Pennsylvania. University of Pittsburgh Cancer Institute University of Pittsburgh, Pittsburgh, Pennsylvania; From the University of Pittsburgh, Pittsburgh, PA; D3 Oncology Solutions (Via Oncology Pathways), an affiliate of the University of Pittsburgh Medical Center, Pittsburgh, PA. Division of Hematology/Oncology, Comprehensive Breast Cancer Center, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania, USA Authors' Affiliations: 1University of California at Los Angeles, Los Angeles; 2Genentech, South San Francisco, California; 3International Drug Development Institute, Louvain-la-Neuve, Belgium; 4Cross Cancer Institute, University of Alberta, Edmonton, Alberta, Canada; 5Virginia Cancer Specialists, US Oncology, Fairfax, Virginia; 6University of Texas MD Anderson Cancer Center, Houston, Texas; 7St. Vincent's Hospital, Dublin, Ireland; 8University of Alabama at Birmingham, Birmingham, Alabama; 9University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania; 10Cancer Center, Warsaw, Poland; 11Redcross Women's Hospital, Muenchen, Germany; 12Hospital Gregorio Maranon, Madrid, Spain; and 13Breast Cancer International Research Group (BCIRG), Paris, France University of Pittsburgh School of Medicine, Pittsburgh, PA, USA |
Incoming Links
Total number of triples: 189.